Progyny, Inc. PGNY

Healthcare · Healthcare Plans · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$644.86M
Market Cap
$2.24B
Margin of Safety
-246.8%
Intrinsic / Market Ratio
0.29

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

743.76M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

438.23M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

752.60M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

644.86M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

644.86M USD

from the sum above

Market Cap

2.24B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.29×

the ratio the screener ranks by; Margin of Safety -246.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 743.76M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)465.89M USD
+②Net Cash Today214.64M USD
+③Growth Value63.23M USD
=Value743.76M USD

EPV of the Operations (NOPAT over WACC)

465.89M USD

Net cash today

+214.64M USD

Growth Value

+63.23M USD

Value

743.76M USD

①EPV (earnings power value)

465.89M USD

②Net Cash Today

214.64M USD

③Growth Value

63.23M USD

Market value

Market Cap2.24B USD

Today's price times the shares.

Value vs market

Margin of Safety-200.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 438.23M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE384.73M USD
+②Equity at Year 15, Today53.50M USD
=Value438.23M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

384.73M USD

②Equity at Year 15, Today

53.50M USD

Market value

Market Cap2.24B USD

Today's price times the shares.

Value vs market

Margin of Safety-410.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 752.60M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF423.30M USD
+②Invested Capital at Year 15, Today114.65M USD
+③Net Cash Today214.64M USD
=Value752.60M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

423.30M USD

②Invested Capital at Year 15, Today

114.65M USD

③Net Cash Today

214.64M USD

Market value

Market Cap2.24B USD

Today's price times the shares.

Value vs market

Margin of Safety-197.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.55%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.02×Market Risk Premium 6.00%= 10.62%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 36.95M USDPretax Income 95.53M USD= 38.68%

The tax the interest saves.

Interest Expense =EBIT 85.36M USD−Pretax Income 95.53M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 22.52M USDMarket Cap + Total Debt 2.24B USD + 22.52M USD= 1.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.00%×Cost of Equity 10.62%+Debt Weight 1.00%×Cost of Debt 4.00%= 10.55%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 716.55M USD − Total Liabilities 262.84M USD = Book Value Today 453.71M USD

Total Debt 22.52M USD − Cash and Short-Term Investments 237.16M USD = Net Debt Today -214.64M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-19.7%at most 5%passes77,390,288 / 96,348,522
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets21.2%at least -10.0%passes(210.40M USD − 58.58M USD) ÷ 716.55M USD
Price to bookMarket Cap ÷ Book Value Today4.93×at most 3×does not pass2.24B USD ÷ 453.71M USD
Operating marginOperating Income ÷ Revenue6.6%above 10.0%does not pass85.36M USD ÷ 1.29B USD
Revenue growthRevenue ÷ Revenue a Year Before − 110.4%above 10.0%passes1.29B USD / 1.17B USD
Net cash(Cash − Total Debt) ÷ Market Cap5.8%above -30%passes(152.78M USD − 22.52M USD) ÷ 2.24B USD
Operating efficiencyOperating Income ÷ Gross Profit28.0%above 25.0%passes85.36M USD ÷ 304.79M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

29 USD

Enterprise value

2.03B USD

market cap plus net debt

EV / EBITDA

16.12×

Price / book

4.93×

the provider's book

Price / earnings

30.98×

Return on equity

16.2%

the provider's, not the engine's

Profit margin

6.0%

Revenue growth

5.3%

Analyst target, mean

34 USD

Analysts

12

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

787.70M1.09B1.17B1.29B

Gross profit

167.49M239.04M253.62M304.79M

Operating income

23.36M62.25M67.52M85.36M

EBITDA

operating income before depreciation and amortisation

24.97M64.53M70.70M90.32M

Pretax income

24.47M70.76M83.29M95.53M

Net income

30.39M62.10M54.39M58.58M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

30.39M62.10M54.39M58.58M

R&D

————
Balance sheet, year end

Total assets

543.53M757.38M607.71M743.18M

Total liabilities

166.18M203.39M185.23M226.62M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

377.34M553.98M422.48M516.56M

Total debt

7.72M19.41M19.29M27.75M

Cash and equivalents

120.20M97.39M162.48M112.35M

Net PP&E

fixed assets after depreciation

15.29M27.85M29.66M54.97M

Working capital

current assets less current liabilities

274.59M454.91M304.40M349.73M
Cash flow

Operating cash flow

80.48M189.00M179.28M210.40M

Capital expenditure

paid out, so below zero

-3.24M-3.65M-5.41M-18.43M

Depreciation and amortisation

1.60M2.28M3.18M4.95M

Free cash flow

operating cash flow plus capital expenditure

77.23M185.36M173.87M191.97M